Health Care Up as Traders Await Policy Statement -- Health Care Roundup

Health-care companies ticked up as traders awaited the Federal Reserve's policy statement midweek.

High-risk niches such as biotech and obesity-drug makers are particularly sensitive to Fed policy. In a two-part deal that could bring a nearly $3 billion windfall for Pfizer, the company plans to sell 630 million shares of Advil maker Haleon, a joint venture between Pfizer and GSK that was spun out into an independent company.

Write to Rob Curran at [e-mail]

(END) Dow Jones Newswires

03-18-24 1755ET